Volume 131, Issue 6, Pages 1674-1682 (December 2006) A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas John A. Baron, Robert S. Sandler, Robert S. Bresalier, Hui Quan, Robert Riddell, Angel Lanas, James A. Bolognese, Bettina Oxenius, Kevin Horgan, Susan Loftus, Dion G. Morton Gastroenterology Volume 131, Issue 6, Pages 1674-1682 (December 2006) DOI: 10.1053/j.gastro.2006.08.079 Copyright © 2006 AGA Institute Terms and Conditions
Figure 1 Enrollment, randomization, follow-up evaluation, and data analysis. The original study design included a rofecoxib 50-mg group; 25 patients were assigned to this treatment before it was decided not to proceed with this arm. ae, adverse event. Gastroenterology 2006 131, 1674-1682DOI: (10.1053/j.gastro.2006.08.079) Copyright © 2006 AGA Institute Terms and Conditions